Speaker

Mark Fielding

Director - Chemistry, Manufacturing, Controls, Regulatory Affairs & Radiopharmaceuticals, AstraZeneca

Mark Fielding, Director - Chemistry, Manufacturing, Controls, Regulatory Affairs & Radiopharmaceuticals at AstraZeneca, is speaking at 8th Targeted Radiopharmaceuticals Summit Europe 2026 (London, United Kingdom, 1–3 Dec 2026) in the session “Navigating Regulatory CMC Challenges Across Kit-Based & Ready-to-Use Radiopharmaceuticals: An Industry Perspective”.

Conferences: 1
Keynotes: 0
Upcoming: 1

Upcoming appearances

8th Targeted Radiopharmaceuticals Summit Europe 2026
1–3 Dec 2026London, United Kingdom
- PanelNavigating Regulatory CMC Challenges Across Kit-Based & Ready-to-Use Radiopharmaceuticals: An Industry PerspectiveWith Sandra Hennig, Anil Lalwani

More speakers at 8th Targeted Radiopharmaceuticals Summit Europe 2026

Friedmund Bachmann
Vice President CMC & Project Lead, OncoOne
Luke Brzozowski
Executive Director - Translational Research & Core Facilities ,Program Sponsor, Theranostics, UHN
Frederic Desdouits
Chief Executive Officer, OranoMed
Chaitanya Divgi
Senior Expert - Strategic Therapeutic Innovation, Novartis
Kemp Dolliver
Director of Research, Brookline Capital Markets
Rich Edwards
Chief Technology Officer, Nuclide Therapeutics

See all 34 speakers on the event page

This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Mark Fielding, and it lists only the talks, sessions and presentations named in those programmes.

Is this you? Claim this profile — every request is read by a person before anything is linked.

To ask for a correction or for this profile to be removed, email [email protected].